120 related articles for article (PubMed ID: 2720681)
1. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.
Kwok CS; Crivici A; MacGregor WD; Unger MW
Cancer Res; 1989 Jun; 49(12):3276-81. PubMed ID: 2720681
[TBL] [Abstract][Full Text] [Related]
2. 131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.
Langmuir VK; McGann JK; Buchegger F; Sutherland RM
Cancer Res; 1989 Jun; 49(12):3401-6. PubMed ID: 2720694
[TBL] [Abstract][Full Text] [Related]
3. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.
Kwok CS; Cole SE; Liao SK
Cancer Res; 1988 Apr; 48(7):1856-63. PubMed ID: 3349464
[TBL] [Abstract][Full Text] [Related]
4. The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivo.
Langmuir VK; Mendonca HL
Radiat Res; 1992 Dec; 132(3):351-8. PubMed ID: 1475358
[TBL] [Abstract][Full Text] [Related]
5. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
6. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
Lindmo T; Boven E; Mitchell JB; Morstyn G; Bunn PA
Cancer Res; 1985 Oct; 45(10):5080-7. PubMed ID: 4027987
[TBL] [Abstract][Full Text] [Related]
7. Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.
Langmuir VK; Mendonca HL; Woo DV
Cancer Res; 1992 Sep; 52(17):4728-34. PubMed ID: 1511438
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.
Li L; Xu HY; Mi L; Bian HJ; Qin J; Xiong H; Feng Q; Wen N; Tian R; Xu LQ; Shen XM; Tang H; Chen ZN
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1238-44. PubMed ID: 16979831
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
Erlichman C; Vidgen D
Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
[TBL] [Abstract][Full Text] [Related]
12. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
[TBL] [Abstract][Full Text] [Related]
14. Effects of 131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids.
Chen FM; Liu CZ; Epstein AL
Cancer Immunol Immunother; 1991; 33(3):158-64. PubMed ID: 2044081
[TBL] [Abstract][Full Text] [Related]
15. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
16. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
Rodriguez A; Alpen EL; Mendonca M; DeGuzman RJ
Radiat Res; 1988 Jun; 114(3):515-27. PubMed ID: 3375440
[TBL] [Abstract][Full Text] [Related]
17. Tumor immunotherapy in the mouse with the use of 131I-labeled monoclonal antibodies.
Zalcberg JR; Thompson CH; Lichtenstein M; McKenzie IF
J Natl Cancer Inst; 1984 Mar; 72(3):697-704. PubMed ID: 6583453
[TBL] [Abstract][Full Text] [Related]
18. Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids.
McFadden R; Kwok CS
Cancer Res; 1988 Jul; 48(14):4032-7. PubMed ID: 3383196
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.
Daghighian F; Barendswaard E; Welt S; Humm J; Scott A; Willingham MC; McGuffie E; Old LJ; Larson SM
J Nucl Med; 1996 Jun; 37(6):1052-7. PubMed ID: 8683300
[TBL] [Abstract][Full Text] [Related]
20. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
